Abstract:Background Neuroinflammation is an important host defense response to secondary brain injury after intracerebral hemorrhage (ICH). Triggering receptor expressed on myeloid cells 2 (TREM2) confers strong neuroprotective effects by attenuating neuroinflammation in experimental ischemic stroke. Recent studies suggest that apolipoprotein E (apoE) is a novel, high-affinity ligand of TREM2. This study aimed to investigate the effects of TREM2 activation on neuroinflammation and neuronal apoptosis in a mouse model of ICH. Methods Adult male CD1 mice (n = 216) were subjected to intrastriatal injection of bacterial collagenase. The TREM2 ligand, apoE-mimetic peptide COG1410 was administered intranasally at 1 h after ICH induction. To elucidate the underlying mechanism, TREM2 small interfering RNA (siRNA) and the phosphatidylinositol 3-kinase (PI3K) inhibitor LY294002 were administered intracerebroventricularly prior to COG1410 treatment. Neurobehavioral tests, brain water content, immunofluorescence, western blotting, and Fluoro-Jade C- and terminal deoxynucleotidyl transferase dUTP nick end labeling staining were performed. Results Endogenous TREM2 expression was increased and peaked at 24 h after ICH. TREM2 was expressed on microglia, astrocytes, and neurons. COG1410 improved both short-term and long-term neurological functions, reduced brain edema, inhibited microglia/macrophage activation and neutrophil infiltration, and suppressed neuronal apoptotic cell death in perihematomal areas after ICH. Knockdown of endogenous TREM2 by TREM2 siRNA aggravated neurological deficits and decreased the expression of TREM2 in naive and ICH mice. COG1410 was associated with upregulation of TREM2, PI3K, phosphorylated-Akt, and Bcl-2 and downregulation of TNF-alpha, IL-1 beta, and Bax after ICH. The neuroprotective effects of COG1410 were abolished by both TREM2 siRNA and PI3K inhibitor LY294002. Conclusions Our finding demonstrated that TREM2 activation improved neurological functions and attenuated neuroinflammation and neuronal apoptosis after ICH, which was, at least in part, mediated by activation of PI3K/Akt signaling pathway. Therefore, activation of TREM2 may be a potential therapeutic strategy for the management of ICH patients.

Expression of TREM-2 and Its Inhibitory Effects on TNF-α Induced Inflammation in Fibroblast-Like Synoviocytes Via Inhibiting P38 Pathway Activation.

Triggering receptor expressed on myeloid cells 2 in synovial tissue of rheumatoid arthritis rats

Identification and Validation of TREM2 in Intracranial Aneurysms

TREM-1 is a positive regulator of TNF-alpha and IL-8 production in U937 foam cells

TREM2 inhibits inflammatory responses in mouse microglia by suppressing the PI3K/NF-κB signaling

TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-κB/CXCL3 axis

TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis

TREM-2 Negatively Regulates LPS-mediated Inflammatory Response in Rat Bone Marrow-Derived MSCs

Triggering Receptor Expressed on Myeloid Cells-2 (TREM-2) Elicited by Lung Cancer Cells to Facilitate Tumor Immune Evasion.

Expression Of Cannabinoid Receptor 2 And Its Inhibitory Effects On Synovial Fibroblasts In Rheumatoid Arthritis

TMEM59 Interacts with TREM2 and Modulates TREM2-dependent Microglial Activities

TREM2 Activation Attenuates Neuroinflammation and Neuronal Apoptosis Via PI3K/Akt Pathway after Intracerebral Hemorrhage in Mice.

Inhibition of TREM-1 ameliorates angiotensin II-induced atrial fibrillation by attenuating macrophage infiltration and inflammation through the PI3K/AKT/FoxO3a signaling pathway

Fibroblast expression of neurotransmitter receptor HTR2A associates with inflammation in rheumatoid arthritis joint

Knockdown of TREM-1 suppresses IL-1β-induced chondrocyte injury via inhibiting the NF-κB pathway.

sTREM2 Differentially Affects Cytokine Expression in Myeloid-Derived Cell Models via MAPK–JNK Signaling Pathway

Knockdown Of Trem-1 Suppresses Il-1 Beta-Induced Chondrocyte Injury Via Inhibiting The Nf-Kappa B Pathway

TREM-1 (triggering receptor expressed on myeloid cells): a new player in acute inflammatory responses.

Effect of Triggering Receptors Expressed on Myeloid Cells-2 on the Apoptosis of Mouse Lung Fibroblasts

Regulation Of Trem2 Expression By An Nf-Kappa B-Sensitive Mirna-34a

TREM2 regulates microglial lipid droplet formation and represses post-ischemic brain injury